GLP-1 receptor agonists and cancer: current clinical evidence and translational opportunities for preclinical research
Imaging and single-cell transcriptomic analyses demonstrate that SGLT2 inhibitors and GLP-1 receptor agonists improve kidney tissue oxygenation and perfusion, respectively [124], and act on distinct kidney cell types [125,126], reinforcing a biological basis for additive or synergistic effects
The FDA took more than 30 years to update a standard for what foods could be labeled as healthy, despite calls for faster oversight of rapidly shifting labeling trends from members of Congress, doctors, and consumer advocates
Increased plasma dipeptidyl peptidase 4 activities predict new-onset microalbuminuria in association with its proinflammatory effects in Chinese without diabetes: a four-year prospective study
The half-life of tirzepatide (the amount of time it takes for the level in your body to half) is around five days
Although this approach is still in its early stages of exploration within the GLP-1 space, continuous and semi-continuous chromatography is already gaining traction elsewhere, such as in oligonucleotide and biologics manufacturing